-
August 23, 2017 Lupin launches generic Seroquel XR® tablets in the US
-
August 21, 2017 Lupin receives EIR from US FDA for Aurangabad, April 2017 Inspection
-
August 14, 2017 Lupin’s alliance partner Natco receives FDA approval for generic Fosrenol Chewable Tablets
-
August 11, 2017 Lupin appoints Mrs. Manju Deshbandhu Gupta as Chairman
-
August 9, 2017 Lupin receives FDA approval for Nikita™ (Pitavastatin) Tablets
-
August 3, 2017 Lupin receives FDA approval for generic Crestor® tablets
-
August 2, 2017 Quarter I, FY2018 – Results
-
August 1, 2017 Lupin receives FDA approval for generic Lidex® Ointment
-
July 31, 2017 Lupin’s Aurangabad facility inspection concluded by US FDA
In this section
Media Contacts
-
Rajalakshmi Azariah
Vice President & Global Head – Corporate Communications